Publication at Second Faculty of Medicine, First Faculty of Medicine |
2013
Abstract
Second line therapy for metastatic renal cell carcinoma is reviewed here, with the focus on tyrosine kinase inhibitors
Second line therapy for metastatic renal cell carcinoma is reviewed here, with the focus on tyrosine kinase inhibitors